This award is named in honour of Rudolf W. Ammann (1926-2015), a Swiss gastroenterologist and professor at the University Hospital Zurich.
Through his long-term observational studies, Rudolf Amman became the great phenomenologist of pancreatology. As early as the 1970s, he pointed out the possible vascular causes of chronic pancreatitis in old age and postulated chronic pancreatitis as a risk factor for pancreatic carcinoma. In his 20-year long-term study of patients with chronic pancreatitis, published in Gastroenterology in 1984, he showed that the intensity of pain decreases with the degree of exocrine pancreatic insufficiency and pancreatic calcification and that after a long course of the disease, pain is often no longer a clinically predominant problem.
He was EPC President 1978 and EPC Treasurer from 1978 to 1989. His work has been honoured with many awards and honorary memberships. In 2001, he received the EPC Lifetime Achievement Award.
This award, presented for the first time, was made possible by a generous donation from the Nordmark Pharma GmbH.
Rudolf Ammann – Life and Work
Markus Lerch will give the introductory lecture on Rudolf Ammann’s life and work. He is physician-in-chief and CEO of LMU University Hospital in Munich. He attended Medical School in Freiburg, Glasgow, Toronto and at the University of Massachusetts. He held research positions at Harvard University, the University of Milano, and the Max-Planck-Institute of Biochemistry in Martinsried. He was the professor of gastroenterology at Greifswald University Medicine. His clinical and research interests are the pathophysiology, cell biology and genetics of pancreatic disorders.
He was EPC President 2018 and EPC Treasurer from 2002 to 2007. In 2016, he received the EPC Lifetime Achievement Award.
EPC 2023 Rudolf Ammann Award
Juliane Glaubitz is the Rudolf Ammann awardee of 2023.
Dr Glaubitz finished her PhD in 2021 at the University Greifswald, Department of Medicine A, on “Studies on the suppressive effect of regulatory T cells on the course of experimental pancreatitis in mice”. From 2012 to 2018, she studied Human Biology at the University of Greifswald. In 2019, she got the Young Investigator Award of the German Pancreas Club (DPC).
In her award-winning publication, Juliane Glaubitz identified CD25+FOXP3+ regulatory T-cells as significant regulators of pancreatic fibrogenesis: Glaubitz J et al. In mouse chronic pancreatitis CD25+FOXP3+ regulatory T cells control pancreatic fibrosis by suppression of the type 2 immune response. Nat Commun. 2022;13(1):4502.